China National Medical Products Administration
GPTKB entity
Statements (51)
| Predicate | Object |
|---|---|
| gptkbp:instanceOf |
government agency
|
| gptkbp:advocatesFor |
for innovation in medical technology
|
| gptkbp:collaboratedWith |
with universities and research institutions
|
| gptkbp:conducts |
public awareness campaigns
risk assessments inspections of manufacturing facilities |
| gptkbp:coordinates |
with international regulatory bodies
with local health authorities |
| gptkbp:develops |
regulatory frameworks
standards for medical devices strategies for combating counterfeit drugs policies for drug pricing |
| gptkbp:enforces |
compliance with regulations
|
| gptkbp:engagesIn |
in public consultations
|
| gptkbp:ensures |
safety of medical products
|
| gptkbp:established |
2018
|
| gptkbp:facilitates |
public-private partnerships in health
market access for new drugs |
| https://www.w3.org/2000/01/rdf-schema#label |
China National Medical Products Administration
|
| gptkbp:issues |
recalls for unsafe products
guidelines for clinical trials public safety alerts certificates of free sale guidelines for biosimilars guidelines for post-marketing surveillance import permits for medical products licenses for pharmaceutical companies warnings about unapproved products |
| gptkbp:locatedIn |
gptkb:China
|
| gptkbp:manages |
the_National_Drug_Evaluation_Center
the_National_Medical_Products_Administration's_website |
| gptkbp:monitors |
adverse drug reactions
|
| gptkbp:oversees |
drug approval process
medical device approval process vaccine approval process |
| gptkbp:parentOrganization |
gptkb:State_Administration_for_Market_Regulation
|
| gptkbp:participatesIn |
in international forums
|
| gptkbp:promotes |
public health
good manufacturing practices |
| gptkbp:provides |
information to the public
training for industry professionals guidance on drug labeling technical assistance to manufacturers support for health emergencies |
| gptkbp:publishes |
annual reports
|
| gptkbp:regulates |
clinical trial applications
blood products and tissues cosmetics and health supplements |
| gptkbp:responsibleFor |
regulating medical products
|
| gptkbp:supports |
pharmacovigilance activities
research and development in pharmaceuticals |